Management of hypertension with fixed-dose triple-combination treatment improves compliance and disease control

Abstract

Arterial hypertension, along with smoking, diabetes, dyslipidaemia, and obesity, is among the most significant risk factors of cardiovascular diseases. In the Czech Republic, the prevalence of hypertension in the adult population (25-64 years old) hovers around 35%, with an increase in older age groups. Achievement of target blood pressure levels in hypertensive patients is unsatisfactory and is around 30% in the Czech Republic. The use of fixed-dose triple-combination of perindopril/indapamide/ amlodipine aids in modifying the most significant factors of poor hypertension control, i.e. inadequate patient compliance and underuse of combination treatment by physicians.